#16
|
|||
|
|||
Ëåæó â áîëüíèöå. Ïðèåõàë äîìîé ïîìûòüñÿ - áëàãî, äðóã ïîäâåç íà àâòî äî ïîäúåçäà. Íàøåë ýïèêðèç ñ ïðîøëîé ãîñïèòàëèçàöèè, ïðèëàãàþ, äëÿ ïîëíîé êàðòèíû.
[Èçîáðàæåíèÿ äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì] |
#17
|
|||
|
|||
Óâàæàåìûé SirKirya! Ïðèâîæó âàì èíòåðåñíûå ññûëêè ïî MS ñ êðàòêèìè ðàçúÿñíåíèÿìè òåêñòà:
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Ïóáëèêàöèÿ èç ñîëèäíîãî èñòî÷íèêà î ðîëè àëüòåðíàòèâíûõ ñðåäñòâ ïðè MS: Äèåòà ñ ïîâûøåííûì ñîäåðæàíèåì ïîëèíåíàñûùåííûõ æèðíûõ êèñëîò ìîæåò äàòü ïîëîæèòåëüíûé ýôôåêò. Vitamin D, ginkgo biloba, cannabinoids, and Padma 28 produce immunomodulatory actions and therapeutic effects in experimental autoimmune encephalomyelitis. Ïåðå÷èñëåííûå ñðåäñòâà îêàçûâàëè ëå÷åáíûé ýôôåêò â ýêñïåðèìåíòå, äàííûõ î ïðèìåíåíèè â êëèíèêå ïîêà íåäîñòàòî÷íî (íåäîñòàòî÷íî íå îçíà÷àåò íåýôôåêòèâíî) (Padma 28- ïðåïàðàò èç òèáåòñêèõ òðàâ, â Ðîññèè ïðîäàåòñÿ ëè, íå çíàþ, â Èòàëèè îäèí ìîé ïàöèåíò ïîêóïàë). Îäíà èç ññûëîê ïîñâÿùåíà ÄÍÊ-âàêöèíå, êîòîðàÿ îêàçàëà ëå÷åáíûé ýôôåêò ïðè íåòÿæåëîé ôîðìå MS, â 2007 äîëæíî áûëî çàâåðøèòüñÿ èññëåäîâàíèå íà áîëüøåì ÷èñëå áîëüíûõ. Ìîåé çàäà÷åé áûëî äàòü âàì ïîëåçíóþ èíôîðìàöèþ, ÷òîáû âû ìîãëè îáñóäèòü åå ñ ëå÷àùèì âðà÷îì; ÿ èìåþ â âèäó âàêöèíó. Ïîäõîäèò èëè íåò âàì ýòà âàêöèíà- ðåøèò âàø âðà÷, ïîñêîëüêó òåðàïåâòû ñ òàêîé ïàòîëîãèåé ñòàëêèâàþòñÿ òîëüêî êîñâåííî.
__________________
Èñðàôèëîâà Øàõëà Þñèôîâíà. Òåðàïåâò, ïóëüìîíîëîã. |
#18
|
|||
|
|||
Øàõëà Þñèôîâíà, áîëüøîå Âàì ñïàñèáî!
Ê ñîæàëåíèþ, ïåðâàÿ ññûëêà â Âàøåì ïðåäûäóùåì ïîñòå ó ìåíÿ íå îòêðûëàñü. Ñíîâà ïðèáûë äîìîé íà âûõîäíûå, â áîëüíèöå ñäåëàëè ïåðâûé ñåàíñ ïëàçìàôåðåçà - âðîäå ñòàëî ëåã÷å, êîîðäèíàöèÿ íåñêîëüêî óëó÷øèëàñü, íî ñëàáîñòü â ìûøöàõ îñòàåòñÿ äîñòàòî÷íî ñèëüíîé. Îáåùàþò ñäåëàòü åù¸ ñåàíñ-äðóãîé, ò.ê., ñóäÿ ïî àíàëèçàì êðîâè ïîñëå íåãî, ó ìåíÿ åù¸ åñòü â êðîâè äîñòàòî÷íî áåëêà äëÿ ïðîäîëæåíèÿ(áåëîê 71,5 ïîñëå ïåðâîãî ñåàíñà ïëàçìàôåðåçà). Ïîñëå ïðèåìîâ ïèùè âñ¸ âðåìÿ óïàäîê ñèë - áûâàåò, ïîñëå îáåäà ñ òðóäîì äîõîæó äî ïàëàòû, òðåáóåòñÿ ìèíóò 5-6 íà 15 ìåòðîâ ïóòè. Çàòî ïî âå÷åðàì õîäèòü ñòàëî çíà÷èòåëüíî ëåã÷å.  áîëüíèöå ïîëó÷èëîñü òàê, ÷òî ýíäîêðèíîëîã óø¸ë â îòïóñê, íî äîëæåí âûéòè 24-ãî ÷èñëà. Íàïðàâëåíèå íà êîíñóëüòàöèþ ìíå ëå÷àùèé âðà÷ íàïèñàë, íî äîäåðæàò ëè ìåíÿ â áîëüíèöå äî âûõîäà ýíäîêðèíîëîãà èç îòïóñêà - íåèçâåñòíî. Íåïîíÿòíî ïî êàêîé ïðè÷èíå, íî âðà÷è íå õîòÿò ïîêàçûâàòü ìíå ìîþ èñòîðèþ áîëåçíè, äàæå àíàëèçû êðîâè, ê ïðèìåðó, òîëüêî ÷èòàþò èõ, è ãîâîðÿò ÷òî òàì ó ìåíÿ âñ¸ â ïîðÿäêå. Íàäåþñü, ê âûïèñêå âñ¸-òàêè ñóìåþ ïîëó÷èòü íà ðóêè ðåçóëüòàòû âñåõ ìîèõ èññëåäîâàíèé, è ïîêàçàòü èõ çäåñü. |
#19
|
|||
|
|||
Ïåðâóþ ññûëêó ÿ âàì ñêîïèðîâàëà:
1: Curr Treat Options Neurol. 2003 Jan;5(1):55-68. Links Current Complementary and Alternative Therapies for Multiple Sclerosis.Bowling AC, Stewart TM. Complementary and Alternative Medicine Program, Rocky Mountain Multiple Sclerosis Center, 701 East Hampden Avenue, #530, Englewood, CO 80110, USA. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] The use of complementary and alternative medicine (CAM) appears to be high in the general population and in patients with multiple sclerosis (MS). There are no diets or dietary supplements that are definitely effective in altering the disease course in MS. However, diets and dietary supplements that increase the intake of polyunsaturated fatty acids may produce mildly beneficial effects. Because these approaches are not definitely effective, they may be of limited interest to physicians and other conventional health providers. In contrast, for patients with MS, these interventions may be of considerable interest, because they may be mildly effective and are inexpensive and relatively safe. Vitamin D, ginkgo biloba, cannabinoids, and Padma 28 produce immunomodulatory actions and therapeutic effects in experimental autoimmune encephalomyelitis. However, for these compounds, there are not enough clinical trial data or safety information to support their use as disease-modifying therapies. The role of antioxidant compounds in MS is unclear. There is no evidence that vitamin B(12) supplementation or gluten-free diets are effective MS therapies. Conventional health providers can play an important role in the care of MS patients by being open to discuss CAM therapies and by providing objective MS-relevant CAM information. PMID: 12521563 [PubMed - as supplied by publisher] (Ïðåïàðàòû ãèíêãî áåëîáà ïðîäàþòñÿ â Ðîññèè).
__________________
Èñðàôèëîâà Øàõëà Þñèôîâíà. Òåðàïåâò, ïóëüìîíîëîã. |
#20
|
|||
|
|||
|
#21
|
|||
|
|||
Âûïèñàëñÿ èç áîëüíèöû. Âûäàëè ýïèêðèç ñ ðåçóëüòàòàìè àíàëèçîâ. Ïðèëàãàþ:
Îáñëåäîâàíèÿ: ÝÊà - âåðòèêàëüíàÿ ÝÎÑ ÓÇÈ ÙÆ. 3-å: Êîëëîèäíàÿ êèñòà â ëåâîé äîëå ÙÆ. ÔÃÄÑ. Õðîíè÷åñêèé ïîâåðõíîñòíûé ãàñòðèò 0-1 ñò. Ëàáîðàòîðíûå äàííûå: ÁÀÊ - áåëîê-64,2 áèë-11,1 ìî÷-6 ãë-5,4 ÀÑÒ-21,5 ÀËÒ-18,5 Ê-4,6 íàò-140 Ñà-12 õëîð-104,9 õîë-4,3 RW-îòðèö. ÎÀÊ - Ë-5,04 í-57 ë-31 ý-8,2 Ýð-5,08 Íâ-151 ãåì-43,2 òðîì-25,8 ÑÎÝ-5 ÎÀÌ - â íîðìå Ëå÷åíèå: âèíïîöåòèí, ïèðàöåòàì, ìèäîêàëì, ñîëó-ìåäðîë, íåéðîìåäèí, ïëàçìàôåðåç (3 ñåàíñà), ËÃ, ËÔÊ. Ïåðåä ÔÃÄÑ ó ìåíÿ ñëó÷èëàñü ïèùåâàÿ àëëåðãèÿ, çà äåíü äî íåãî - áîëè â æèâîòå, ïîíîñ, îòåê Êâèíêå. Äàëè 2 òàáë. ëîðàòàäèíà - ïðîøëî. Õîòåëîñü áû óçíàòü, ÷òî òàêîå êîëëîèäíàÿ êèñòà â ùèòîâèäêå - íó è êàê ðåçóëüòàòû àíàëèçîâ - íåëüçÿ ëè ïî íèì ïðî Â12-äåôèöèòíóþ àíåìèþ ÷òî-íèáóäü óçíàòü. Ïîïàñòü ê ýíäîêðèíîëîãó â áîëüíèöå íå óäàëîñü - îí áûë â îòïóñêå. Âîò, ñîáñòâåííî, è âñ¸. Õîòåë áû åù¸ ñêàçàòü, ÷òî íà ýòîì ôîðóìå ÿ õîòåë óçíàòü ó ñïåöèàëèñòîâ âîçìîæíûå äðóãèå ïðè÷èíû ìîåãî ñîñòîÿíèÿ, íåæåëè ðàññåÿííûé ñêëåðîç, êîòîðûé ñòàâÿò ìíå íåâðîëîãè íàøè. Âñå-òàêè, ÷òî-íèáóäü äðóãîå ìîæåò è ìîæíî áûëî áû âûëå÷èòü - â îòëè÷èå îò ñêëåðîçà ýòîãî. Åù¸ ðàç ñïàñèáî âñåì îòêëèêíóâøèìñÿ. |
#22
|
|||
|
|||
Ïîïðîñèòå ìîäåðàòîðà ïîìåíÿòü íàçâàíèå òåìû, äîáàâèòü "Ðàññåÿííûé ñêëåðîç", ÷òîáû íåâðîëîãè îáðàòèëè âíèìàíèå. Èëè íàïèøèòå èì â ËÑ, ïîïðîñèòå çàãëÿíóòü â ýòó òåìó. Òîëüêî îíè ìîãóò ñêàçàòü, ñ ÷åì íàäî äèôôåðåíöèðîâàòü ÐÑ.
Âû ñïðîñèëè âðà÷åé â êëèíèêå î ëå÷åáíîé âàêöèíå? Ïî ðåçóëüòàòàì ýòèõ àíàëèçîâ íå ïîõîæå, ÷òî ó âàñ åñòü Â-12 äåôèöèò.
__________________
Èñðàôèëîâà Øàõëà Þñèôîâíà. Òåðàïåâò, ïóëüìîíîëîã. |
|
#23
|
|||
|
|||
Íåò, â áîëüíèöå ÿ ïðî âàêöèíó ê ñîæàëåíèþ íå ñïðàøèâàë, çàáûâàë âñå âðåìÿ ïðî íå¸ êîãäà îáõîäû áûëè. Î÷åíü õîòåëîñü ïîêàçàòüñÿ êàê ìîæíî áîëüøåìó ÷èñëó âðà÷åé è ñäåëàòü ðàçíûå îáñëåäîâàíèÿ, âîò âñå è íå óïîìíèë.
Îáÿçàòåëüíî ñïðîøó ó ñâîåãî íåâðîëîãà â ïîëèêëèíèêå - îíà êàê-íèêàê çàâ. íåâðîëîãè÷åñêèì îòäåëåíèåì. |
#24
|
||||
|
||||
Êîëëîèäíàÿ êèñòà - íåóäà÷íî èñïîëüçîâàííûå óçèñòîì ïîñëå íåíóæíîãî îáñëåäîâàíèÿ íåíóæíûå ñëîâà
__________________
Ã.À. Ìåëüíè÷åíêî |